Tumor suppressor menin mediates peripheral nerve injury-induced neuropathic pain through potentiating synaptic plasticity

Neuroscience

Volumn 223, Issue , 2012, Pages 473-485

  Xu, S ^a   Wu, H ^a   Wang, X ^a   Shen, X ^a   Guo, X ^a   Shen, R ^a   Wang, F ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Menin; Nerve injury; Neuropathic pain; Spinal cord; Synaptic plasticity

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MENIN PROTEIN; NEURON SPECIFIC NUCLEAR PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIAL; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; MALE; MECHANICAL HYPERSENSITIVITY; MONOSYNAPTIC POTENTIAL; MOUSE; NERVE CELL; NERVE CELL PLASTICITY; NEUROPATHIC HYPERSENSITIVITY; NEUROPATHIC PAIN; NEUROPATHY; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPINAL CORD; SYNAPTOGENESIS; THERMAL HYPERSENSITIVITY;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; AREA UNDER CURVE; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; ELECTRIC STIMULATION; EMBRYO, MAMMALIAN; EXCITATORY POSTSYNAPTIC POTENTIALS; GENE EXPRESSION REGULATION; HYPERALGESIA; MALE; MICE; MICE, INBRED C57BL; NEURALGIA; NEURONS; OLIGONUCLEOTIDES, ANTISENSE; PAIN MEASUREMENT; PAIN THRESHOLD; PERIPHERAL NERVE INJURIES; PHOSPHOPYRUVATE HYDRATASE; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SPINAL CORD;

EID: 84866488750     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.07.036     Document Type: Article

References (56)

1. Agnati L.F., Zoli M., Pich E.M., Benfenati F., Fuxe K. Aspects of neural plasticity in the central nervous system-VII. Theoretical aspects of brain communication and computation. Neurochem Int 1990, 16:479-500.
2. Bekkers J.M. Quantal analysis of synaptic transmission in the central nervous system. Curr Opin Neurobiol 1994, 4:360-365.
3. Bird G.C., Han J.S., Fu Y., Adwanikar H., Willis W.D., Neugebauer V. Pain-related synaptic plasticity in spinal dorsal horn neurons: role of CGRP. Mol Pain 2006, 2:31.
4. Burry R.W. Specificity controls for immunocytochemical methods. J Histochem Cytochem 2000, 48:163-166.
5. Catterall W.A., Few A.P. Calcium channel regulation and presynaptic plasticity. Neuron 2008, 59:882-901.
6. Chao D.L., Ma L., Shen K. Transient cell-cell interactions in neural circuit formation. Nat Rev Neurosci 2009, 10:262-271.
7. Chomczynski P., Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 2006, 1:581-585.
8. Cooper M.S., Przebinda A.S. Synaptic conversion of chloride-dependent synapses in spinal nociceptive circuits: roles in neuropathic pain. Pain Res Treat 2011, 2011:738645.
9. Crooke R.M., Graham M.J., Martin M.J., Lemonidis K.M., Wyrzykiewiecz T., Cummins L.L. Metabolism of antisense oligonucleotides in rat liver homogenates. J Pharmacol Exp Ther 2000, 292:140-149.
10. Darian-Smith C. Synaptic plasticity, neurogenesis, and functional recovery after spinal cord injury. Neuroscientist 2009, 15:149-165.
11. Decosterd I., Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000, 87:149-158.
12. Deller T., Mundel P., Frotscher M. Potential role of synaptopodin in spine motility by coupling actin to the spine apparatus. Hippocampus 2000, 10:569-581.
13. Dent M.A., Segura-Anaya E., Alva-Medina J., Aranda-Anzaldo A. NeuN/Fox-3 is an intrinsic component of the neuronal nuclear matrix. FEBS Lett 2010, 584:2767-2771.
14. Fossat P., Dobremez E., Bouali-Benazzouz R., Favereaux A., Bertrand S.S., Kilk K., Léger C., Cazalets J.R., Langel U., Landry M., Nagy F. Knockdown of L calcium channel subtypes: differential effects in neuropathic pain. J Neurosci 2010, 30:1073-1085.
15. Giordano J., Schatman M.E. A crisis in chronic pain care: an ethical analysis. Part three: toward an integrative, multi-disciplinary pain medicine built around the needs of the patient. Pain Physician 2008, 11:775-784.
16. Hantman A.W., van den Pol A.N., Perl E.R. Morphological and physiological features of a set of spinal substantia gelatinosa neurons defined by green fluorescent protein expression. J Neurosci 2004, 24:836-842.
17. Ikeda H., Kiritoshi T., Murase K. Synaptic plasticity in the spinal dorsal horn. Neurosci Res 2009, 64:133-136.
18. Jaken R.J., Joosten E.A., Knüwer M., Favereaux A., Bertrand S.S., Kilk K., Léger C., Cazalets J.R., Langel U., Landry M., Nagy F. Synaptic plasticity in the substantia gelatinosa in a model of chronic neuropathic pain. Neurosci Lett 2010, 469:30-33.
19. Ji R.R., Woolf C.J. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 2001, 8:1-10.
20. 2+ and synaptotagmin: insights from a large CNS synapse. Trends Neurosci 2011, 34:237-246.
21. Kohno T., Moore K.A., Baba H., Woolf C.J. Peripheral nerve injury alters excitatory synaptic transmission in lamina II of the rat dorsal horn. J Physiol 2003, 548:131-138.
22. Langley P., Müller-Schwefe G., Nicolaou A., Liedgens H., Pergolizzi J., Varrassi G. The impact of pain on labor force participation, absenteeism and presenteeism in the European Union. J Med Econ 2010, 13:662-672.
23. Larsson M., Broman J. Synaptic plasticity and pain: role of ionotropic glutamate receptors. Neuroscientist 2011, 17:256-273.
24. Latremoliere A., Woolf C.J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009, 10:895-926.
25. Lin J.Y., Peng B., Yang Z.W., Min S. Number of synapses increased in the rat spinal dorsal horn after sciatic nerve transection: a stereological study. Brain Res Bull 2011, 84:430-433.
26. Macleod G.T., Zinsmaier K.E. Synaptic homeostasis on the fast track. Neuron 2006, 52:569-571.
27. O'Connor A.B. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics 2009, 27:95-112.
28. Onifer S.M., Smith G.M., Fouad K. Plasticity after spinal cord injury: relevance to recovery and approaches to facilitate it. Neurotherapeutics 2011, 8:283-293.
29. Ossipov M.H., Dussor G.O., Porreca F. Central modulation of pain. J Clin Invest 2010, 120:3779-3787.
30. Peng B., Lin J.Y., Shang Y., Yang Z.W., Wang Y.P. Plasticity in the synaptic number associated with neuropathic pain in the rat spinal dorsal horn: a stereological study. Neurosci Lett 2010, 486:24-28.
31. Pockett S. Long-term potentiation and depression in the intermediate gray matter of rat spinal cord in vitro. Neuroscience 1995, 67:791-798.
32. Ramakers G.M., Pasinelli P., Hens J.J., Gispen W.H., De Graan P.N. Protein kinase C in synaptic plasticity: changes in the in situ phosphorylation state of identified pre- and postsynaptic substrates. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21:455-486.
33. Ruscheweyh R., Wilder-Smith O., Drdla R., Liu X.G., Sandkühler J. Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy. Mol Pain 2011, 7:20.
34. Sandkühler J., Liu X. Induction of long-term potentiation at spinal synapses by noxious stimulation or nerve injury. Eur J Neurosci 1998, 10:2476-2480.
35. Schwartzman R.J., Grothusen J., Kiefer T.R., Rohr P. Neuropathic central pain: epidemiology, etiology, and treatment options. Arch Neurol 2001, 58:1547-1550.
36. Simpson H.D., Mortimer D., Goodhill G.J. Theoretical models of neural circuit development. Curr Top Dev Biol 2009, 87:1-51.
37. Smith B.H., Elliott A.M., Chambers W.A., Smith W.C., Hannaford P.C., Penny K. The impact of chronic pain in the community. Fam Pract 2001, 18:292-299.
38. Sowa H., Kaji H., Canaff L., Hendy G.N., Tsukamoto T., Yamaguchi T., Miyazono K., Sugimoto T., Chihara K. Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage. J Biol Chem 2003, 278:21058-21069.
39. Spitzer N.C. Activity-dependent neurotransmitter respecification. Nat Rev Neurosci 2012, 13:94-106.
40. Stewart C., Parente F., Piehl F., Farnebo F., Quincey D., Silins G., Bergman L., Carle G.F., Lemmens I., Grimmond S., Xian C.Z., Khodei S., Teh B.T., Lagercrantz J., Siggers P., Calender A., Van de Vem V., Kas K., Weber G., Hayward N., Gaudray P., Larsson C. Characterization of the mouse Men1 gene and its expression during development. Oncogene 1998, 17:2485-2493.
41. Südhof T.C. Calcium control of neurotransmitter release. Cold Spring Harb Perspect Biol 2012, 4:a011353.
42. Taylor R.S. Epidemiology of refractory neuropathic pain. Pain Pract 2006, 6:22-26.
43. Torrance N., Smith B.H., Bennett M.I., Lee A.J. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 2006, 7:281-289.
44. Turk D.C., Wilson H.D., Cahana A. Treatment of chronic non-cancer pain. Lancet 2011, 377:2226-2235.
45. van Kesteren R.E., Syed N.I., Munno D.W., Bouwman J., Feng Z.P., Geraerts W.P., Smit A.B. Synapse formation between central neurons requires postsynaptic expression of the MEN1 tumor suppressor gene. J Neurosci 2001, 21:RC161.
46. Vetter T.R. The application of economic evaluation methods in the chronic pain medicine literature. Anesth Analg 2007, 105:114-118.
47. Voronin L.L. Intrasynaptic ephaptic feedback in central synapses. Neurosci Behav Physiol 2000, 30:575-585.
48. Wang F., Shen X., Guo X., Peng Y., Liu Y., Xu S., Yang J. Spinal macrophage migration inhibitory factor contributes to the pathogenesis of inflammatory hyperalgesia in rats. Pain 2010, 148:275-283.
49. Wang F., Wu H., Xu S., Guo X., Yang J., Shen X. Macrophage migration inhibitory factor activates cyclooxygenase 2-prostaglandin E2 in cultured spinal microglia. Neurosci Res 2011, 71:210-218.
50. Wang F., Xu S., Shen X., Guo X., Peng Y., Yang J. Spinal macrophage migration inhibitory factor is a major contributor to rodent neuropathic pain-like hypersensitivity. Anesthesiology 2011, 114:643-659.
51. Weaver S., Dube S., Mir A., Qin J., Sun G., Ramakrishnan R., Jones R.C., Livak K.J. Taking qPCR to a higher level: analysis of CNV reveals the power of high throughput qPCR to enhance quantitative resolution. Methods 2010, 50:271-276.
52. Woolf C.J. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011, 152:S2-S15.
53. Zeilhofer H.U. Synaptic modulation in pain pathways. Rev Physiol Biochem Pharmacol 2005, 154:73-100.
54. Zeilhofer H.U. Loss of glycinergic and GABAergic inhibition in chronic pain - contributions of inflammation and microglia. Int Immunopharmacol 2008, 8:182-187.
55. Zhang X., Poo M.M. Progress in neural plasticity. Sci China Life Sci 2010, 53:322-329.
56. Zhang X., Chen G., Xue Q., Yu B. Early changes of beta-Catenins and Menins in spinal cord dorsal horn after peripheral nerve injury. Cell Mol Neurobiol 2010, 30:885-890.